These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1464 related articles for article (PubMed ID: 25752327)

  • 1. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.
    Park JW; Chen M; Colombo M; Roberts LR; Schwartz M; Chen PJ; Kudo M; Johnson P; Wagner S; Orsini LS; Sherman M
    Liver Int; 2015 Sep; 35(9):2155-66. PubMed ID: 25752327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.
    Kudo M; Lencioni R; Marrero JA; Venook AP; Bronowicki JP; Chen XP; Dagher L; Furuse J; Geschwind JF; Ladrón de Guevara L; Papandreou C; Sanyal AJ; Takayama T; Yoon SK; Nakajima K; Lehr R; Heldner S; Ye SL
    Liver Int; 2016 Aug; 36(8):1196-205. PubMed ID: 26901163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: an Asian perspective.
    Teo EK; Fock KM
    Dig Dis; 2001; 19(4):263-8. PubMed ID: 11935085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma.
    Chen M; Therneau T; Orsini LS; Qiao YL
    BMC Gastroenterol; 2011 May; 11():53. PubMed ID: 21569429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries.
    Wang BE; Ma WM; Sulaiman A; Noer S; Sumoharjo S; Sumarsidi D; Tandon BN; Nakao K; Mishiro S; Miyakawa Y; Akahane Y; Suzuki H
    J Med Virol; 2002 Jul; 67(3):394-400. PubMed ID: 12116033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy.
    Debes JD; Chan AJ; Balderramo D; Kikuchi L; Gonzalez Ballerga E; Prieto JE; Tapias M; Idrovo V; Davalos MB; Cairo F; Barreyro FJ; Paredes S; Hernandez N; Avendaño K; Diaz Ferrer J; Yang JD; Carrera E; Garcia JA; Mattos AZ; Hirsch BS; Gonçalves PT; Carrilho FJ; Roberts LR
    Liver Int; 2018 Jan; 38(1):136-143. PubMed ID: 28640517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global trends and predictions in hepatocellular carcinoma mortality.
    Bertuccio P; Turati F; Carioli G; Rodriguez T; La Vecchia C; Malvezzi M; Negri E
    J Hepatol; 2017 Aug; 67(2):302-309. PubMed ID: 28336466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in the treatment of hepatocellular carcinoma with transarterial embolization: a cross-sectional survey of techniques.
    Young S; Craig P; Golzarian J
    Eur Radiol; 2019 Jun; 29(6):3287-3295. PubMed ID: 30350163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
    Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
    J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
    Yim SY; Seo YS; Jung CH; Kim TH; Lee JM; Kim ES; Keum B; Jong YK; An H; Kim JH; Yim HJ; Kim DS; Jeen YT; Yeon JE; Lee HS; Chun HJ; Byun KS; Um SH; Kim CD; Ryu HS
    Liver Int; 2016 Mar; 36(3):445-53. PubMed ID: 26352789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
    J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.
    McGlynn KA; Petrick JL; London WT
    Clin Liver Dis; 2015 May; 19(2):223-38. PubMed ID: 25921660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
    Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
    Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
    Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
    World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.